Karkatshringi (Pistacia integerrima)

Karkatshringi (Pistacia integerrima) contains bioactive compounds including tannins and phenolic acids that exhibit anti-inflammatory effects through COX enzyme inhibition. This Ayurvedic herb traditionally supports respiratory health and demonstrates preliminary anticancer potential in laboratory studies.

Origin & History

Karkatshringi is derived from insect-induced galls formed on the leaves of Pistacia integerrima, a deciduous tree native to the Himalayan regions of India, Pakistan, and Afghanistan. These hollow, cylindrical galls are harvested, dried, and processed through methods like hydrodistillation or methanolic extraction to obtain bioactive compounds including essential oils, flavonoids, and tannins.

Historical & Cultural Context

Karkatshringi has been used in Ayurvedic medicine for over 2,000 years, primarily for respiratory ailments, fever, and digestive issues. The herb features prominently in traditional formulations like Chyawanprash, Dashmularista, and Karkatadi Churna, and is valued for its expectorant, tonic, and blood purifying properties.

Health Benefits

• Respiratory support: Traditional use for cough, asthma, and tuberculosis (evidence quality: traditional use only, no clinical trials)
• Anti-inflammatory effects: Methanolic extracts showed COX enzyme inhibition in animal models (evidence quality: preliminary animal studies)
• Anticancer potential: In vitro studies showed 60% growth inhibition at 500 ppm and reduced lung cancer cell viability (evidence quality: preliminary cell studies)
• Antimicrobial activity: Demonstrated effects against staphylococci, pseudomonas, and E. coli in laboratory tests (evidence quality: preliminary in vitro)
• Anticonvulsant properties: Essential oils containing alpha-pinene and beta-pinene showed effects in animal models (evidence quality: preliminary animal studies)

How It Works

Karkatshringi's methanolic extracts inhibit cyclooxygenase (COX) enzymes, reducing inflammatory mediator production. The phenolic compounds and tannins present in the herb modulate inflammatory pathways and may interfere with cellular signaling involved in respiratory conditions. Its bioactive constituents also demonstrate potential cytotoxic effects on cancer cell lines through mechanisms that require further investigation.

Scientific Research

No human clinical trials, RCTs, or meta-analyses have been conducted on Karkatshringi. All available evidence comes from preclinical studies including animal models showing anti-inflammatory effects via COX inhibition and in vitro studies demonstrating anticancer activity against lung cancer cell lines (A549, NCI-H460). No PubMed PMIDs are available for any studies.

Clinical Summary

Current research on Karkatshringi is limited to traditional use documentation and preliminary animal studies. Animal models have shown COX enzyme inhibition with methanolic extracts, but no human clinical trials have been conducted. In vitro studies suggest anticancer potential, though specific mechanisms and efficacy remain unestablished. The evidence base relies primarily on traditional Ayurvedic applications for respiratory conditions rather than controlled clinical research.

Nutritional Profile

{"macronutrients": {"protein": "5-10% of dry weight", "fiber": "15-20% of dry weight"}, "micronutrients": {"vitamin_C": "10-20 mg/100g", "calcium": "100-150 mg/100g", "iron": "2-5 mg/100g"}, "bioactive_compounds": {"terpenoids": "1-2% of dry weight", "flavonoids": "0.5-1% of dry weight", "tannins": "2-4% of dry weight"}, "bioavailability_notes": "Bioactive compounds may have variable absorption rates; traditional preparation methods may enhance bioavailability."}

Preparation & Dosage

Traditional Ayurvedic dosage: 2-4 grams per day as powder or decoction. No clinically studied dosages for standardized extracts are available. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Tulsi, Licorice, Ginger, Pippali, Vasaka

Safety & Interactions

Safety data for Karkatshringi is limited due to lack of comprehensive clinical studies. Traditional use suggests general tolerability, but potential side effects, optimal dosing, and long-term safety remain unestablished. Drug interactions are unknown and may occur with anti-inflammatory medications due to COX enzyme effects. Pregnant and breastfeeding women should avoid use due to insufficient safety data.